Literature DB >> 6848451

Human antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected autologous and allogeneic cells.

S Kohl, C M Moore.   

Abstract

Using cultured skin shavings, human cellular cytotoxicity to uninfected and herpes simplex virus (HSV)-infected autologous and allogeneic fibroblasts and Chang liver cells was analysed in a 51Cr release assay. The effector cell requirements and characterization, time kinetics and antibody requirements were similar using each HSV-infected target cell in an antibody-dependent cellular cytotoxicity (ADCC) system. There was lower natural killer cytotoxicity (NKC) to uninfected autologous cells than unrelated cells in an 18 hr assay. NKC to infected autologous and unrelated fibroblasts was similar to that mediated against Chang liver cells. Thus NKC to uninfected fibroblasts correlated with the relationship of effector and target cells while NKC to infected cells correlated with the intrinsic lytic potential of the effector cells. The autologous system offers little advantage in the analysis of ADCC or NKC in normal individuals to virus-infected cells, but is probably crucial for the detection of HLA-restricted T-cell cytotoxicity. The demonstration of autologous anti-viral ADCC and NKC lends further credence to the in vivo importance of the mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6848451      PMCID: PMC1454015     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Lysis of herpesvirus-infected cells by immune spleen cells.

Authors:  I A Ramshaw
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.

Authors:  S L Shore; C M Black; F M Melewicz; P A Wood; A J Nahmias
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

3.  Immune destruction of virus-infected cells early in the infectious cycle.

Authors:  S L Shore; T L Cromeans; T J Romano
Journal:  Nature       Date:  1976-08-19       Impact factor: 49.962

4.  Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus.

Authors:  S L Shore; A J Nahmias; S E Starr; P A Wood; D E McFarlin
Journal:  Nature       Date:  1974-09-27       Impact factor: 49.962

5.  Immunological destruction of herpes simplex virus I infected cells.

Authors:  B Rager-Zisman; B R Bloom
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  Interferon induction of natural killer cytotoxicity in human neonates.

Authors:  S Kohl; J J Frazier; S B Greenberg; L K Pickering; L S Loo
Journal:  J Pediatr       Date:  1981-03       Impact factor: 4.406

7.  The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.

Authors:  S L Shore; F M Melewicz; D S Gordon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Inhibition by rheumatoid factor, anti-FC, and staphylococcal protein A of antibody-dependent cell-mediated cytolysis against Herpes simplex virus-infected cells.

Authors:  R M Austin; C A Daniels
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

9.  Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.

Authors:  A S Russell; J T Kaiser
Journal:  J Allergy Clin Immunol       Date:  1976-11       Impact factor: 10.793

10.  Induction of natural killer cells by herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains.

Authors:  D Armerding; H Rossiter
Journal:  Immunobiology       Date:  1981       Impact factor: 3.144

View more
  1 in total

1.  Rosette-formation in herpes simplex and herpes zoster lesions as demonstrated in Tzanck smears.

Authors:  C Nieboer; R Beljaards; J P van der Veen
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.